StockWatch
·

Biogen Pharmachem Industries Ltd Q4 FY25 Results

BIOGENQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue1.35
Total Income1.35493.1%
Expenditure0.1767.9%
PBT1.18473.9%
Net Profit1.18473.9%
OPM87.10%
NPM87.10%
EPS0.02
View full financials

Informational and educational content only. Not investment advice.